DOD Amyotrophic Lateral Sclerosis, Clinical Outcomes and Biomarkers Award
GRANTS.GOV
Due: August 27, 2025 at 12:00 AM UTC
ActiveGrant
GRANTS.GOVDue: August 27, 2025 at 12:00 AM UTC
ActiveGrant
Summary
The DOD Amyotrophic Lateral Sclerosis, Clinical Outcomes and Biomarkers Award is a grant opportunity aimed at advancing research in the field of Amyotrophic Lateral Sclerosis (ALS). This initiative seeks to support projects that focus on clinical outcomes and the identification of biomarkers associated with ALS, which is crucial for improving diagnosis, treatment, and understanding of the disease. Contractors or businesses with expertise in biomedical research, clinical trials, and biomarker development are encouraged to apply, particularly those with a strong background in neurology and related fields. The awarded projects are expected to contribute significantly to the scientific community's understanding of ALS and potentially lead to improved patient care.